Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 84

    1.

    Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine.

    Manner H, Jung B, Tonassi L, Hackenberg U, Plum N, Josten KM, Kirchmaier CM, Frickhofen N.

    Am J Med Sci. 2008 May;335(5):394-7.PMID: 18480659 [PubMed - indexed for MEDLINE]Related articles

    2.

    Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up.

    Zander AR, Schmoor C, Kröger N, Krüger W, Möbus V, Frickhofen N, Metzner B, Berdel WE, Koenigsmann M, Thiel E, Wandt H, Possinger K, Kreienberg R, Schumacher M, Jonat W.

    Ann Oncol. 2008 Jun;19(6):1082-9. Epub 2008 Feb 27.PMID: 18304964 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT.

    Möbus V, Wandt H, Frickhofen N, Bengala C, Champion K, Kimmig R, Ostermann H, Hinke A, Ledermann JA; AGO-Ovar/AIO; EBMT.

    J Clin Oncol. 2007 Sep 20;25(27):4187-93. Epub 2007 Aug 13.PMID: 17698804 [PubMed - indexed for MEDLINE]Related articles

    4.

    Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer.

    Frickhofen N, Berdel WE, Opri F, Haas R, Schneeweiss A, Sandherr M, Kuhn W, Hossfeld DK, Thomssen C, Heimpel H, Kreienberg R, Hinke A, Möbus V; German Study Groups Arbeitsgemeinschaft Internistische Onkologie (AIO); Arbeitsgemeinschaft Gynäkologische Onkologie (AGO).

    Bone Marrow Transplant. 2006 Oct;38(7):493-9. Epub 2006 Aug 21.PMID: 16980997 [PubMed - indexed for MEDLINE]Related articles

    5.

    High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.

    Illerhaus G, Marks R, Ihorst G, Guttenberger R, Ostertag C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J.

    J Clin Oncol. 2006 Aug 20;24(24):3865-70. Epub 2006 Jul 24.PMID: 16864853 [PubMed - indexed for MEDLINE]Related articles

    6.

    Aplastic anemia.

    Kojima S, Frickhofen N, Deeg HJ, Okamoto S, Marsh J, Teramura M, Bacigalupo A, Mizoguchi H.

    Int J Hematol. 2005 Dec;82(5):408-11. No abstract available. PMID: 16533743 [PubMed - indexed for MEDLINE]Related articles

    7.

    A phase I and pharmacokinetic study of novel taxane BMS-188797 and cisplatin in patients with advanced solid tumours.

    du Bois A, Jung B, Loehr A, Schaller-Kranz T, Cohen M, Frickhofen N.

    Br J Cancer. 2006 Jan 16;94(1):79-84.PMID: 16333310 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.

    Köhne CH, van Cutsem E, Wils J, Bokemeyer C, El-Serafi M, Lutz MP, Lorenz M, Reichardt P, Rückle-Lanz H, Frickhofen N, Fuchs R, Mergenthaler HG, Langenbuch T, Vanhoefer U, Rougier P, Voigtmann R, Müller L, Genicot B, Anak O, Nordlinger B; European Organisation for Research and Treatment of Cancer Gastrointestinal Group.

    J Clin Oncol. 2005 Aug 1;23(22):4856-65. Epub 2005 Jun 6.PMID: 15939923 [PubMed - indexed for MEDLINE]Related articles

    9.

    t(14;18) and bcl-2 should not be used synonymously.

    Frickhofen N.

    Ann Oncol. 2004 Nov;15(11):1723. No abstract available. PMID: 15520081 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Subgroup specific therapy effects in AML: AMLCG data.

    Büchner T, Hiddemann W, Berdel WE, Wörmann B, Schoch C, Fonatsch C, Löffler H, Haferlach T, Ludwig WD, Maschmeyer G, Staib P, Balleisen L, Grüneisen A, Aul C, Lengfelder E, Hehlmann R, Kern W, Serve HL, Mesters RM, Eimermacher H, Frickhofen N, Kienast J, Giagounidis A, Sauerland MC, Heinecke A; German AMLCG.

    Ann Hematol. 2004;83 Suppl 1:S100-1. No abstract available. PMID: 15124694 [PubMed - indexed for MEDLINE]Related articles

    11.

    High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.

    Zander AR, Kröger N, Schmoor C, Krüger W, Möbus V, Frickhofen N, Metzner B, Schultze W, Berdel WE, Koenigsmann M, Thiel E, Wandt H, Possinger K, Trümper L, Kreienberg R, Carstensen M, Schmidt EH, Jänicke F, Schumacher M, Jonat W.

    J Clin Oncol. 2004 Jun 15;22(12):2273-83. Epub 2004 Apr 26.PMID: 15111618 [PubMed - indexed for MEDLINE]Related articles

    12.

    Complete molecular remission of chronic eosinophilic leukemia complicated by CNS disease after targeted therapy with imatinib.

    Frickhofen N, Märker-Hermann E, Reiter A, Walz C, Jung B, Bauer H, Hochhaus A.

    Ann Hematol. 2004 Jul;83(7):477-80. Epub 2004 Feb 18.PMID: 14986065 [PubMed - indexed for MEDLINE]Related articles

    13.

    6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.

    Büchner T, Hiddemann W, Berdel WE, Wörmann B, Schoch C, Fonatsch C, Löffler H, Haferlach T, Ludwig WD, Maschmeyer G, Staib P, Aul C, Gruneisen A, Lengfelder E, Frickhofen N, Kern W, Serve HL, Mesters RM, Sauerland MC, Heinecke A; German AML Cooperative Group.

    J Clin Oncol. 2003 Dec 15;21(24):4496-504.PMID: 14673036 [PubMed - indexed for MEDLINE]Related articles

    14.

    A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma.

    Einsele H, Bamberg M, Budach W, Schmidberger H, Hess CF, Wörmann B, Meisner C, Straka C, Hebart H, Trümper L, Kröger N, Zander AR, Hegewisch-Becker S, Hossfeld DK, Schmidt H, Müller P, Schlimok G, Hertenstein B, Peest D, Metzner B, Frickhofen N, Kanz L, Bensinger WI.

    Bone Marrow Transplant. 2003 Sep;32(6):593-9.PMID: 12953132 [PubMed - indexed for MEDLINE]Related articles

    15.

    Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.

    Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H; German Aplastic Anemia Study Group.

    Blood. 2003 Feb 15;101(4):1236-42. Epub 2002 Oct 10.PMID: 12393680 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.

    von Rohr A, Schmitz SF, Tichelli A, Hess U, Piguet D, Wernli M, Frickhofen N, Konwalinka G, Zulian G, Ghielmini M, Rufener B, Racine C, Fey MF, Cerny T, Betticher D, Tobler A; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.

    Ann Oncol. 2002 Oct;13(10):1641-9.PMID: 12377655 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression.

    Tichelli A, Socié G, Marsh J, Barge R, Frickhofen N, McCann S, Bacigalupo A, Hows J, Marin P, Nachbaur D, Symeonidis A, Passweg J, Schrezenmeier H; European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.

    Ann Intern Med. 2002 Aug 6;137(3):164-72.PMID: 12160364 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil.

    Frickhofen N, Beck FJ, Jung B, Fuhr HG, Andrasch H, Sigmund M.

    Ann Oncol. 2002 May;13(5):797-801.PMID: 12075751 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Acute myeloid leukemia: treatment over 60.

    Büchner T, Hiddemann W, Berdel W, Wörmann B, Schoch C, Löffler H, Haferlach T, Schumacher A, Staib P, Balleisen L, Grüneisen A, Rasche H, Aul C, Heyll A, Lengfelder E, Ludwig WD, Maschmeyer G, Eimermacher H, Karow J, Frickhofen N, Hirschmann WD, Sauerland MC; German AML Co-Operative Group.

    Rev Clin Exp Hematol. 2002 Mar;6(1):46-59; discussion 86-7. Review.PMID: 12060483 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels.

    Hofmann WK, Seipelt G, Ottmann OG, Kalina U, Koschmieder S, Brücher J, Frickhofen N, Klausmann M, Mitrou PS, Hoelzer D.

    Ann Hematol. 2000 May;79(5):255-8.PMID: 10870480 [PubMed - indexed for MEDLINE]Related articles

    21.

    Late clonal diseases of treated aplastic anemia.

    Socié G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A.

    Semin Hematol. 2000 Jan;37(1):91-101. Review.PMID: 10676914 [PubMed - indexed for MEDLINE]Related articles

    22.

    Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine.

    Frickhofen N, Rosenfeld SJ.

    Semin Hematol. 2000 Jan;37(1):56-68. Review.PMID: 10676911 [PubMed - indexed for MEDLINE]Related articles

    23.

    [Stem cell supported high dose chemotherapy (HDCT) in primary treatment of advanced ovarian carcinoma]

    Möbus V, von Schilling C, Kreienberg R, Wiesneth M, Bergmann L, Frickhofen N.

    Praxis (Bern 1994). 1999 Mar 18;88(12):507-12. Review. German. PMID: 10235025 [PubMed - indexed for MEDLINE]Related articles

    24.

    Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma.

    Kotzerke J, Guhlmann A, Moog F, Frickhofen N, Reske SN.

    Eur J Nucl Med. 1999 Jan;26(1):31-8.PMID: 9933659 [PubMed - indexed for MEDLINE]Related articles

    25.

    Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease.

    Bangerter M, Moog F, Buchmann I, Kotzerke J, Griesshammer M, Hafner M, Elsner K, Frickhofen N, Reske SN, Bergmann L.

    Ann Oncol. 1998 Oct;9(10):1117-22.PMID: 9834825 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation.

    Schmitz N, Bacigalupo A, Hasenclever D, Nagler A, Gluckman E, Clark P, Bourquelot P, Greinix H, Frickhofen N, Ringdén O, Zander A, Apperley JF, Gorin C, Borkett K, Schwab G, Goebel M, Russell NH, Gratwohl A.

    Bone Marrow Transplant. 1998 May;21(10):995-1003.PMID: 9632272 [PubMed - indexed for MEDLINE]Related articles

    27.

    HCV and HGV in B-cell non-Hodgkin's lymphoma.

    Ellenrieder V, Weidenbach H, Frickhofen N, Michel D, Prümmer O, Klatt S, Bernas O, Mertens T, Adler G, Beckh K.

    J Hepatol. 1998 Jan;28(1):34-9.PMID: 9537861 [PubMed - indexed for MEDLINE]Related articles

    28.

    18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.

    Moog F, Bangerter M, Kotzerke J, Guhlmann A, Frickhofen N, Reske SN.

    J Clin Oncol. 1998 Feb;16(2):603-9.PMID: 9469348 [PubMed - indexed for MEDLINE]Related articles

    29.

    Extranodal malignant lymphoma: detection with FDG PET versus CT.

    Moog F, Bangerter M, Diederichs CG, Guhlmann A, Merkle E, Frickhofen N, Reske SN.

    Radiology. 1998 Feb;206(2):475-81.PMID: 9457202 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Rearranged Ig heavy chain DNA is detectable in cell-free blood samples of patients with B-cell neoplasia.

    Frickhofen N, Müller E, Sandherr M, Binder T, Bangerter M, Wiest C, Enz M, Heimpel H.

    Blood. 1997 Dec 15;90(12):4953-60.PMID: 9389714 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Concomitant manifestation of systemic lupus erythematosus and low-grade non-Hodgkin's lymphoma.

    Munzert G, Frickhofen N, Bauditz J, Schreiber S, Herrmann F.

    Leukemia. 1997 Aug;11(8):1324-8.PMID: 9264388 [PubMed - indexed for MEDLINE]Related articles

    32.

    Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation.

    Locasciulli A, Testa M, Pontisso P, Bacigalupo A, Ljungman P, Frickhofen N, Alberti A.

    Bone Marrow Transplant. 1997 Feb;19(3):237-40.PMID: 9028552 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Haematopoietic reconstitution after autologous transplantation of CD34(+)-selected versus non-selected peripheral blood progenitor cells.

    Wiesneth M, Schreiner T, Sandherr M, Maccari B, Erne E, Bischof C, Frickhofen N, von Schilling C, Kubanek B.

    Beitr Infusionsther Transfusionsmed. 1997;34:133-8.PMID: 9356664 [PubMed - indexed for MEDLINE]Related articles

    34.

    High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.

    Zander AR, Krüger W, Kröger N, Damon L, Königmann M, Berdel WE, Gieseking F, Schäfer-Eckart K, Möbus V, Frickhofen N, Wandt H, Illiger HJ, Metzner B, Kolbe K, Wörmann B, Trümper L, Huber C, Hossfeld DK, Maass H, Jonat W.

    Bone Marrow Transplant. 1996 Sep;18 Suppl 1:S24-5. No abstract available. PMID: 8899165 [PubMed - indexed for MEDLINE]Related articles

    35.

    Reversible metastatic pulmonary calcification in a patient with multiple myeloma.

    Weber CK, Friedrich JM, Merkle E, Prümmer O, Hoffmeister A, Mattfeldt T, Frickhofen N.

    Ann Hematol. 1996 May;72(5):329-32.PMID: 8645747 [PubMed - indexed for MEDLINE]Related articles

    36.

    Is blood a better source of allogeneic hematopoietic stem cells for use after radiation accidents?

    Frickhofen N, Körbling M, Fliedner TM.

    Bone Marrow Transplant. 1996 Feb;17(2):131-5. Review.PMID: 8640157 [PubMed - indexed for MEDLINE]Related articles

    37.

    New diagnostic imaging procedures in Hodgkin's disease.

    Bangerter M, Griesshammer M, Binder T, Hafner M, Heimpel H, Reske SN, Frickhofen N.

    Ann Oncol. 1996;7 Suppl 4:55-9. Review.PMID: 8836411 [PubMed - indexed for MEDLINE]Related articles

    38.

    [Parvovirus B19--a ubiquitous, little know virus. From erythema infectiosum and arthropathy to chronic anemia]

    Frickhofen N.

    Fortschr Med. 1995 Sep 10;113(25):351-3. German. No abstract available. PMID: 7498847 [PubMed - indexed for MEDLINE]Related articles

    39.

    The genotype of hepatitis C virus does not affect severity of liver disease after bone marrow transplantation.

    Locasciulli A, Pontisso P, Alberti A, Bacigalupo A, Ljungman P, Frickhofen N.

    Blood. 1995 May 1;85(9):2640. No abstract available. PMID: 7727791 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    [Interferon therapy of chronic hepatitis C in hemophilia]

    Frickhofen N, Ellbrück D, Seifried E.

    Dtsch Med Wochenschr. 1995 Feb 3;120(5):157. German. No abstract available. PMID: 7843037 [PubMed - indexed for MEDLINE]Related articles

    41.

    Cytomegalovirus in liver biopsies of marrow transplant recipients: detection methods, clinical, histological and immunohistological features.

    Einsele H, Waller HD, Weber P, Frickhofen N, Dette S, Horny HP, Roos A, Roos H, Hebart H, Schmidt H, et al.

    Med Microbiol Immunol. 1994 Sep;183(4):205-16.PMID: 7845317 [PubMed - indexed for MEDLINE]Related articles

    42.

    Parvovirus B19 as a cause of acquired chronic pure red cell aplasia.

    Frickhofen N, Chen ZJ, Young NS, Cohen BJ, Heimpel H, Abkowitz JL.

    Br J Haematol. 1994 Aug;87(4):818-24.PMID: 7986722 [PubMed - indexed for MEDLINE]Related articles

    43.

    Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation.

    Frickhofen N, Wiesneth M, Jainta C, Hertenstein B, Heymer B, Bianchi L, Dienes HP, Koerner K, Bunjes D, Arnold R, et al.

    Blood. 1994 Apr 1;83(7):1998-2004.PMID: 7511444 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.

    Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van't Veer-Korthof E, Gluckman E.

    N Engl J Med. 1993 Oct 14;329(16):1152-7.PMID: 8377778 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Parvovirus B19 infection and bone marrow transplantation.

    Frickhofen N, Arnold R, Hertenstein B, Wiesneth M, Young NS.

    Ann Hematol. 1992 Jun;64 Suppl:A121-4. Review.PMID: 1637889 [PubMed - indexed for MEDLINE]Related articles

    46.

    Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C?

    Hibbs JR, Frickhofen N, Rosenfeld SJ, Feinstone SM, Kojima S, Bacigalupo A, Locasciulli A, Tzakis AG, Alter HJ, Young NS.

    JAMA. 1992 Apr 15;267(15):2051-4.PMID: 1313118 [PubMed - indexed for MEDLINE]Related articles

    47.

    First continuous propagation of B19 parvovirus in a cell line.

    Shimomura S, Komatsu N, Frickhofen N, Anderson S, Kajigaya S, Young NS.

    Blood. 1992 Jan 1;79(1):18-24.PMID: 1728307 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response.

    Yoshimoto K, Rosenfeld S, Frickhofen N, Kennedy D, Hills R, Kajigaya S, Young NS.

    J Virol. 1991 Dec;65(12):7056-60.PMID: 1719240 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    A rapid method of sample preparation for detection of DNA viruses in human serum by polymerase chain reaction.

    Frickhofen N, Young NS.

    J Virol Methods. 1991 Nov;35(1):65-72.PMID: 1666114 [PubMed - indexed for MEDLINE]Related articles

    50.

    Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisolone.

    Herrmann F, Lindemann A, Lange W, Köchling G, Raghavachar A, Schrezenmeier H, Frickhofen N, Mertelsmann RH.

    Ann Hematol. 1991 Oct;63(4):229-31.PMID: 1932305 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...